Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

Treatment of Chronic Migraine with Focus on Botulinum Neurotoxins

Migraine is the most common neurological disorder, and contributes to disability and large healthcare costs in the United States and the world. The treatment of migraine until recently has focused on medications, both abortive and prophylactic, but treatment of chronic migraine has been revolutioniz...

Full description

Bibliographic Details
Main Authors:	Sara M. Schaefer, Christopher H. Gottschalk, Bahman Jabbari
Format:	Article
Language:	English
Published:	MDPI AG 2015-07-01
Series:	Toxins
Subjects:	botulinum toxin migraine headache chronic migraine chronic daily headache neurotoxins medication overuse headache
Online Access:	http://www.mdpi.com/2072-6651/7/7/2615

Similar Items

Effect of botulinum toxin on improving quality of life in patients with chronic migraine
by: Magdalena Marzęda, et al.
Published: (2022-09-01)

OnabotulinumtoxinA for the treatment of headache: an updated review
by: Joseph H. Talbet, et al.
Published: (2022-01-01)

Botulinum Toxin—A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches
by: Katarzyna Kępczyńska, et al.
Published: (2022-09-01)

Daily Headache in Chronic Migraine Is a Predictive Factor of Response in Patients Who Had Completed Three Sessions of OnabotulinumtoxinA
by: Enrique Martínez-Pías, et al.
Published: (2021-06-01)

OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse
by: Edoardo Caronna, et al.
Published: (2018-10-01)

Monocentric Prospective Study into the Sustained Effect of Incobotulinumtoxin A (XEOMIN®) Botulinum Toxin in Chronic Refractory Migraine
by: Ioana Ion, et al.
Published: (2018-06-01)

Prevention of medication overuse and medication overuse headache in patients with migraine: a randomized, controlled, parallel, allocation-blinded, multicenter, prospective trial using a mobile software application
by: Hans-Christoph Diener, et al.
Published: (2022-05-01)

The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine
by: Paolo Martelletti
Published: (2018-01-01)

Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine
by: Mariarosaria Valente, et al.
Published: (2021-05-01)

Clinical features of episodic migraine and transformed migraine: a comparative study
by: José Carlos Busto Galego, et al.
Published: (2002-12-01)

Botulinum toxin type A wear-off phenomenon in chronic migraine patients: how long does the maximum efficiency last?
by: Aygul Tantik PAK, et al.
Published: (2021-09-01)

Effects of Botulinum Toxin on Migraine Attack Features in Chronic Migraine: A Six-Month Open-Label Observation Study through Electronic Diary Smartphone Application
by: Antonio Santoro, et al.
Published: (2019-11-01)

Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real‐world clinical evidence in a severely impaired patient population
by: Simona Guerzoni, et al.
Published: (2023-06-01)

Theory of mind in chronic migraine with medication overuse assessed with the MASC
by: Sara Bottiroli, et al.
Published: (2024-03-01)

Differences in Frontal Lobe Dysfunction in Patients with Episodic and Chronic Migraine
by: Sang-Hwa Lee, et al.
Published: (2021-06-01)

Features of Primary Chronic Headache in Children and Adolescents and Validity of Ichd 3 Criteria
by: Laura Papetti, et al.
Published: (2019-02-01)

The Impact of OnabotulinumtoxinA vs. Placebo on Efficacy Outcomes in Headache Day Responder and Nonresponder Patients with Chronic Migraine
by: Stephen D. Silberstein, et al.
Published: (2020-10-01)

Abuse of medications for the treatment of migraines: results of an online survey
by: Nadezhda A. Koval'chuk, et al.
Published: (2021-11-01)

Results of treating Patients with Chronic Migraine with OnabotulinumtoxinA alone Versus Its Combination with Other Prophylactic Drugs
by: Saber Abdelrohman, et al.
Published: (2022-04-01)

Efficacy of Onabotulinum Toxin A on Obsessive–Compulsive Traits in a Population of Chronic Migraine Patients
by: Giovanna Viticchi, et al.
Published: (2022-11-01)

Plasma Levels of Oxidative Stress Markers, before and after <i>BoNT/A</i> Treatment, in Chronic Migraine
by: Elisa Dini, et al.
Published: (2019-10-01)

The CHESS trial: protocol for the process evaluation of a randomised trial of an education and self-management intervention for people with chronic headache
by: Vivien P. Nichols, et al.
Published: (2019-06-01)

Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refractory migraine
by: Jennifer Robblee
Published: (2023-09-01)

Overuse of symptomatic medications among chronic (transformed) migraine patients: profile of drug consumption
by: Abouch Valenty Krymchantowski
Published: (2003-03-01)

Conventional and unconventional treatments for migraine
by: Katarzyna Mielniczek, et al.
Published: (2023-09-01)

Efficacy and safety of eptinezumab in patients with chronic migraine and medication-overuse headache: a randomized, double-blind, placebo-controlled study
by: Shengyuan Yu, et al.
Published: (2023-12-01)

Managing Migraine: Medication Overuse Headache and Treatment with Eptinezumab
by: Nicole Limberg
Published: (2023-06-01)

Muscle tenderness and psychiatric comorbidity: a vicious cycle in migraine chronicization.
by: Eugenia eRota, et al.
Published: (2014-08-01)

Editorial: Women in science: headache
by: Danielle D. DeSouza, et al.
Published: (2023-11-01)

Comprehensive Criteria for Differential Diagnosis and a Surgical Management Algorithm for Occipital Neuralgia and Migraine Headaches
by: Bahman Guyuron, et al.
Published: (2024-03-01)

Traumatic Experiences, Stressful Events, and Alexithymia in Chronic Migraine With Medication Overuse
by: Sara Bottiroli, et al.
Published: (2018-05-01)

Medication Overuse Headaches among Children—The Contribution of Migraine and TTH
by: Jacob Genizi, et al.
Published: (2023-09-01)

Treatment for chronic daily headache by using auxiliary and alternative methods
by: V. A. Golovacheva, et al.
Published: (2015-06-01)

Altered functional connectivity of the right caudate nucleus in chronic migraine: a resting-state fMRI study
by: Ziyu Yuan, et al.
Published: (2022-12-01)

Migraine and other headaches /
by: 219113 Young, William B. (William Boyd), 1959-, et al.
Published: (c200)

Role of educational programs in management of patients with medication-overuse headache
by: A. E. Shagbazyan, et al.
Published: (2021-06-01)

Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?
by: Gibler RC, et al.
Published: (2022-09-01)

BOTULINUM TOXIN FOR THE TREATMENT OF CHRONIC HEADACHE
by: L. B. Zavaliy, et al.
Published: (2016-03-01)

Efficacy of mindfulness added to treatment as usual in patients with chronic migraine and medication overuse headache: a phase-III single-blind randomized-controlled trial (the MIND-CM study)
by: Licia Grazzi, et al.
Published: (2023-07-01)

Clinical Utility of Leeds Dependence Questionnaire in Medication-Overuse Headache
by: Yen-Feng Wang, et al.
Published: (2023-01-01)